News | July 01, 2021
Sun Pharma launches 'Sunkalp' on National Doctors' Day
Sun Pharma has committed Rs. 100 crores towards these initiatives
Sun Pharma has committed Rs. 100 crores towards these initiatives
The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
Subscribe To Our Newsletter & Stay Updated
